day 1 agenda
| 6th Edition of Innovations and State of the Art in ALZHEIMER'S & DEMENTIA at Oct 01 - 02, 2025 at Berlin, Germany (Hybrid Event) |
|
| Day -1(October 01, 2025) | |
| Tentative Program | |
| Talk-1 | KeynoteTalk: Novel Tau-specific aptamers : diagnostic and therapeutic potentials |
| Kevin K. Wang, CNMB, USA | |
| Talk-2 | Slot Available |
| Talk-3 | KeynoteTalk: Neurogenesis And Plasticity Processes Are Similarly Affected And Damaged In Alzheimer´s Disease |
| José Julio Rodríguez Arellano, IKERBASQUE, Spain | |
| Refreshment Break | |
| Talk-4 | Changes in expression of VGF, SPECC1L, HLA-DRA and RANBP3L act with APOE E4 to alter risk for late onset Alzheimer’s disease |
| Amanda J. Myers, University of Miami, USA | |
| Talk-5 | Slot Available |
| Talk-6 | A randomized feasibility trial of the modified Atkins diet in older adults with mild cognitive impairment due to Alzheimer’s disease |
| Alison Buchholz, The Johns Hopkins University School of Medicine, USA | |
| Talk-7 | Cerebral Capillopathy Nexus of Neurodegenerative disease |
| Charles R Joseph, Liberty University College of Osteopathic Medicine, USA | |
| Talk-8 | Sex-specific brain protection in the clinical scenario: the case of davuentide |
| Illana Gozes, Tel Aviv University, Israel | |
| Talk-9 | Slot Available |
| Talk-10 | Potential association of neuronal membrane cholesterol and APP levels with astrocytic de novo cholesterol synthesis, influenced by sex-dependent sublethal copper concentration |
| Arnal Nathalie, INIBIOLP, Argentina | |
| Lunch Break@Restuarant | |
| Talk-11 | ‘Di-phenylalanine’ unit (FF) acts as the Nucleation site for beta-Amyloid Plaque Formation: Unraveling the Mechanisms of Alzheimer’s Disease |
| Raja Banerjee, MAKAUT, India | |
| Talk-12 | Electromagnetic field stimulation ameliorates cognitive deficits and induces neurogenesis in Alzheimer’s disease rat model |
| Suman Jain, AIIMS, India | |
| Talk-13 | Slot Available |
| Talk-14 | In vitro validation of RARβ-M, Ellorarxine, for use in Alzheimers disease |
| Paul Chazot, Durham University, UK | |
| Talk-15 | Slot Available |
| Talk-16 | Revised Criteria for Diagnosis and Staging of Alzheimer's Disease |
| Clifford R. Jack, Mayo Clinic, USA | |
| Talk-17 | Verbal training can improve neurocognitive and reading performance by increasing white matter integrity and grey matter volume |
| Ching-Chi Hsu, Wizcare Medical Corporation Aggregate, Taiwan | |
| Talk-18 | Slot Available |
| Talk-19 | P re existing cognitive disorders and Long COVID neurocognitive sequelae : Why Do We Know So Little? |
| Caroline Jose,Vital ité Health Network, , Canada | |
| Refreshment Break | |
| Talk-20 | Pain & Ageing: Where are we now and what needs to be done? |
| Pat Schofield, University of Plymouth, UK | |
| Talk-21 | Slot Available |
| Talk-22 | Associations of combined accelerated biological aging and genetic susceptibility with incident dementia: a prospective study in the UK Biobank |
| Jiawei Xin, Fujian Medical University , China | |
| Abstract submissions are open now. To schedule your talk in the program please email to: dementiacongress@innovinc.org | |
| Day-1 Concludes | |
day 2 agenda
| Day -2(October 02, 2025) | |
| Tentative Program | |
| Talk-1 | KeynoteTalk: SCA4 is caused by a GGC repeat expansion in ZFHX3 encoding poly-glycine and impairing autophagic flux |
| Stefan Pulst, University of Utah, USA | |
| Talk-2 | Slot Available |
| Talk-3 | KeynoteTalk: Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial |
| Dean Ornish, Preventive Medicine Research Institute, USA | |
| Refreshment Break | |
| Talk-4 | Association of plasma retinol and cognitive function in the middle aged and the elderly with dyslipidemia |
| Xiuwen Ren, Capital Medical University, China | |
| Talk-5 | Slot Available |
| Talk-6 | Concussion-Related Biomarkers in Retired Rugby Players and Implications for Alzheimer’s Disease and ALS Risk: The UK Rugby Health Study |
| Paul Chazot, Durham University, UK | |
| Talk-7 | Association of physical activity and dietary diversity with cognitive function in the elderly with type 2 diabetes mellitus: findings from a cross-sectional study |
| Yu Liu, Capital Medical University, China | |
| Talk-8 | An integrative review about electrophysiological biomarkers of cognitive impairment in Alzheimer’s disease: A developing relationship |
| Ezra C. Holston, University of Nevada Reno, USA | |
| Talk-9 | Slot Available |
| Talk-10 | Association of lifestyle, dietary pattern, and liver function with cognition in older adults: findings from a cross-sectional study |
| Xixiang Wang, Capital Medical University, China | |
| Talk-11 | Successes and Challenges: Insights from the first six months of the CONNECT program |
| Chitrali R. Mamlekar, Misericordia University, USA | |
| Lunch Break@Restuarant | |
| Poster Presentations | |
| PP-1 | In vitro validation of RARβ-M, Ellorarxine, for use in Alzheimer's disease |
| Yunxi Zhang, Durham University, UK | |
| PP-2 | FUS-mediated Blood-brain barrier disruption for delivering anti-A? antibodies in 5XFAD Alzheimer’s disease mice |
| Christakis Damianou, Cyprus University of Technology, Cyprus | |
| PP-3 | Slot Available |
| PP-4 | Concussion-Related Biomarkers in Retired Rugby Players and Implications for Alzheimer’s Disease and ALS Risk: The UK Rugby Health Study |
| Norah Alanazi, Durham University, UK | |
| PP-5 | Slot Available |
| Abstract submissions are open now. To schedule your talk in the program please email to: dementiacongress@innovinc.org | |
| Day-2 Concludes | |
posters agenda
| Day -2(October 02, 2025) | |
| Poster Presentations | |
| PP-1 | In vitro validation of RARβ-M, Ellorarxine, for use in Alzheimers disease |
| Yunxi Zhang, Durham University, UK | |
| PP-2 | FUS-mediated Blood-brain barrier disruption for delivering anti-A? antibodies in 5XFAD Alzheimer’s disease mice |
| Christakis Damianou, Cyprus University of Technology, Cyprus | |
| PP-3 | Slot Available |
| PP-4 | Concussion-Related Biomarkers in Retired Rugby Players and Implications for Alzheimer’s Disease and ALS Risk: The UK Rugby Health Study |
| Norah Alanazi, Durham University, UK | |
| PP-5 | Slot Available |
| Abstract submissions are open now. To schedule your talk in the program please email to: dementiacongress@innovinc.org | |